🇮🇱 Yartemlea in Israel

Yartemlea (NARSOPLIMAB) regulatory status in Israel.

Marketing authorisation

MOH

  • Marketing authorisation holder: OMEROS CORP
  • Status: likely_approved

Yartemlea in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Israel

Frequently asked questions

Is Yartemlea approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Yartemlea in Israel?

OMEROS CORP holds the Israeli marketing authorisation.